Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
JAMA Pediatr. 2022 Sep 1;176(9):915-923. doi: 10.1001/jamapediatrics.2022.2423.
Presence of developmental delays in autism is well established, yet few studies have characterized variability in developmental milestone attainment in this population.
To characterize variability in the age at which autistic individuals attain key developmental milestones based on co-occurring intellectual disability (ID), presence of a rare disruptive genetic variant associated with neurodevelopmental disorders (NDD), age at autism diagnosis, and research cohort membership.
The study team harmonized data from 4 cross-sectional autism cohorts: the Autism Genetics Research Exchange (n = 3284; 1997-2015), The Autism Simplex Collection (n = 694; 2008-2011), the Simons Simplex Collection (n = 2753; 2008-2011), and the Simons Foundation Powering Autism Research for Knowledge (n = 10 367; 2016-present). The last sample further included 4145 siblings without an autism diagnosis or ID.
Convenience sample of 21 243 autistic individuals or their siblings without an autism diagnosis aged 4 to 17 years.
Parents reported ages at which participants attained key milestones including smiling, sitting upright, crawling, walking, spoon-feeding self, speaking words, speaking phrases, and acquiring bladder and bowel control. A total of 5295 autistic individuals, and their biological parents, were genetically characterized to identify de novo variants in NDD-associated genes. The study team conducted time-to-event analyses to estimate and compare percentiles in time with milestone attainment across autistic individuals, subgroups of autistic individuals, and the sibling sample.
Seventeen thousand ninety-eight autistic individuals (mean age, 9.15 years; 80.8% male) compared with 4145 siblings without autism or ID (mean age, 10.2 years; 50.2% female) showed delays in milestone attainment, with median (IQR) delays ranging from 0.7 (0.3-1.6) to 19.7 (11.4-32.2) months. More severe and more variable delays in autism were associated with the presence of co-occurring ID, carrying an NDD-associated rare genetic variant, and being diagnosed with autism by age 5 years. More severe and more variable delays were also associated with membership in earlier study cohorts, consistent with autism's diagnostic and ascertainment expansion over the last 30 years.
As the largest summary to date of developmental milestone attainment in autism, to our knowledge, this study demonstrates substantial developmental variability across different conditions and provides important context for understanding the phenotypic and etiological heterogeneity of autism.
自闭症患者存在发育迟缓已得到充分证实,但很少有研究描述该人群在达到关键发育里程碑方面的可变性。
根据共同存在的智力障碍(ID)、与神经发育障碍(NDD)相关的罕见破坏基因变异的存在、自闭症诊断年龄和研究队列成员情况,描述自闭症个体达到关键发育里程碑的年龄的可变性。
研究小组协调了来自 4 个自闭症横断面队列的数据:自闭症基因研究交换(n=3284;1997-2015 年)、自闭症单纯型收集(n=694;2008-2011 年)、西蒙斯单纯型收集(n=2753;2008-2011 年)和西蒙斯基金会自闭症研究动力知识(n=10367;2016 年至今)。最后一个样本还包括 4145 名没有自闭症诊断或 ID 的兄弟姐妹。
便利样本中的 21243 名自闭症患者或其兄弟姐妹,年龄在 4 至 17 岁之间。
父母报告了参与者达到关键里程碑的年龄,包括微笑、坐直、爬行、行走、用勺子喂食自己、说话、说短语以及获得膀胱和肠道控制。共有 5295 名自闭症患者及其生物父母进行了基因特征分析,以确定与 NDD 相关基因中的新生变异。研究小组进行了时间事件分析,以估计和比较自闭症患者、自闭症患者亚组和兄弟姐妹样本在达到里程碑方面的百分比。
17098 名自闭症患者(平均年龄为 9.15 岁;80.8%为男性)与 4145 名无自闭症或 ID 的兄弟姐妹(平均年龄为 10.2 岁;50.2%为女性)相比,在达到里程碑方面存在延迟,中位数(IQR)延迟范围从 0.7(0.3-1.6)到 19.7(11.4-32.2)个月。共同存在的 ID、携带与 NDD 相关的罕见基因突变以及 5 岁前被诊断为自闭症与自闭症更严重和更可变的延迟有关。更严重和更可变的延迟也与更早的研究队列成员有关,这与过去 30 年来自闭症的诊断和确定扩张一致。
作为迄今为止自闭症发育里程碑达到情况的最大总结,据我们所知,这项研究表明自闭症在不同情况下存在大量的发育可变性,并为理解自闭症的表型和病因异质性提供了重要背景。